Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Michael Snell, APRN

Family Jasper, IN Male

NPI: 1588226856

Total Payments

$28.19

2021 Payments

$28.19

Companies

Transactions

Medicare Patients

2,202

Medicare Billing

$66,320

Payment Breakdown by Category

Food & Beverage$28.19 (100.0%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Food and Beverage	$28.19	2	100.0%

Top Paying Companies

Company	Total	Records	Latest Year
Genentech USA, Inc.	$28.19	2	$0 (2021)

Payment History by Year

Year	Amount	Transactions	Top Company
2021	$28.19	2	Genentech USA, Inc. ($28.19)

All Payment Transactions

2 individual payment records from CMS Open Payments

Date	Company	Product	Nature	Form	Amount	Type
12/07/2021	Genentech USA, Inc.	Xofluza (Drug)	Food and Beverage	In-kind items and services	$14.53	General
Category: Virology & Specialty Care
01/19/2021	Genentech USA, Inc.	Xofluza (Drug)	Food and Beverage	In-kind items and services	$13.66	General
Category: Virology & Specialty Care

Medicare Billing by Year

Year	Procedures	Beneficiaries	Services	Submitted	Medicare Paid
2023	10	336	509	$147,596	$11,579
2022	8	792	1,459	$109,774	$23,085
2021	6	646	1,171	$56,331	$21,187
2020	7	428	693	$36,630	$10,469

Total Patients

2,202

Total Services

3,832

Medicare Billing

$66,320

Procedure Codes

All Medicare Procedures & Services

31 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS	Description	Setting	Year	Patients	Services	Charges	Medicare Paid	Ratio
99284	Emergency department visit with moderate level of medical decision making	Facility	2023	38	38	$38,000	$2,907	7.7%
99283	Emergency department visit with low level of medical decision making	Facility	2023	58	59	$41,300	$2,625	6.4%
99285	Emergency department visit with high level of medical decision making	Facility	2023	20	21	$36,750	$2,333	6.3%
99214	Established patient office or other outpatient visit, 30-39 minutes	Office	2023	55	60	$16,320	$1,827	11.2%
99203	New patient office or other outpatient visit, 30-44 minutes	Office	2023	23	23	$6,394	$731.35	11.4%
87811	Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)	Office	2023	14	14	$1,120	$562.15	50.2%
99213	Established patient office or other outpatient visit, 20-29 minutes	Office	2023	11	11	$2,046	$283.80	13.9%
96372	Injection of drug or substance under skin or into muscle	Office	2023	54	59	$3,776	$258.45	6.8%
81002	Urinalysis, manual test	Office	2023	11	12	$300.00	$40.92	13.6%
J1100	Injection, dexamethasone sodium phosphate, 1 mg	Office	2023	52	212	$1,590	$10.53	0.7%
99214	Established patient office or other outpatient visit, 30-39 minutes	Office	2022	180	214	$50,915	$12,553	24.7%
99203	New patient office or other outpatient visit, 30-44 minutes	Office	2022	120	120	$30,035	$5,500	18.3%
96372	Injection of drug or substance under skin or into muscle	Office	2022	190	210	$12,222	$1,415	11.6%
87804	Detection test by immunoassay with direct visual observation for influenza virus	Office	2022	36	74	$3,686	$1,203	32.6%
99213	Established patient office or other outpatient visit, 20-29 minutes	Office	2022	23	23	$4,072	$1,120	27.5%
87811	Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)	Office	2022	27	28	$2,240	$1,095	48.9%
81002	Urinalysis, manual test	Office	2022	39	42	$994.00	$144.10	14.5%
J1100	Injection, dexamethasone sodium phosphate, 1 mg	Office	2022	177	748	$5,610	$54.66	1.0%
99214	Established patient outpatient visit, total time 30-39 minutes	Office	2021	179	222	$28,638	$13,725	47.9%
99203	New patient outpatient visit, total time 30-44 minutes	Office	2021	106	106	$15,370	$5,860	38.1%
96372	Injection beneath the skin or into muscle for therapy, diagnosis, or prevention	Office	2021	156	174	$6,090	$1,272	20.9%
81002	Urinalysis, manual test	Office	2021	46	51	$918.00	$177.48	19.3%
J1040	Injection, methylprednisolone acetate, 80 mg	Office	2021	15	16	$800.00	$96.54	12.1%
J1100	Injection, dexamethasone sodium phosphate, 1 mg	Office	2021	144	602	$4,515	$57.45	1.3%
99214	Established patient office or other outpatient, visit typically 25 minutes	Office	2020	127	148	$19,092	$6,594	34.5%

1 2 »

About Michael Snell, APRN

Michael Snell, APRN is a Family healthcare provider based in Jasper, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2019. The National Provider Identifier (NPI) number assigned to this provider is 1588226856.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Snell, APRN has received a total of $28.19 in payments from pharmaceutical and medical device companies, with $28.19 received in 2021. These payments were reported across 2 transactions from 1 company. The most common payment nature is "Food and Beverage" ($28.19).

As a Medicare-enrolled provider, Snell has provided services to 2,202 Medicare beneficiaries, totaling 3,832 services with total Medicare billing of $66,320. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Family
Location Jasper, IN
Active Since 07/08/2019
Last Updated 09/25/2019
Taxonomy Code 363LF0000X
Entity Type Individual
NPI Number 1588226856

Products in Payments

Xofluza (Drug) $28.19

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.